Correlation Between EirGenix and SynCore Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EirGenix and SynCore Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EirGenix and SynCore Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EirGenix and SynCore Biotechnology Co, you can compare the effects of market volatilities on EirGenix and SynCore Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EirGenix with a short position of SynCore Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of EirGenix and SynCore Biotechnology.

Diversification Opportunities for EirGenix and SynCore Biotechnology

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between EirGenix and SynCore is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding EirGenix and SynCore Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SynCore Biotechnology and EirGenix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EirGenix are associated (or correlated) with SynCore Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SynCore Biotechnology has no effect on the direction of EirGenix i.e., EirGenix and SynCore Biotechnology go up and down completely randomly.

Pair Corralation between EirGenix and SynCore Biotechnology

Assuming the 90 days trading horizon EirGenix is expected to generate 0.81 times more return on investment than SynCore Biotechnology. However, EirGenix is 1.24 times less risky than SynCore Biotechnology. It trades about 0.05 of its potential returns per unit of risk. SynCore Biotechnology Co is currently generating about -0.11 per unit of risk. If you would invest  9,300  in EirGenix on August 31, 2024 and sell it today you would earn a total of  120.00  from holding EirGenix or generate 1.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

EirGenix  vs.  SynCore Biotechnology Co

 Performance 
       Timeline  
EirGenix 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in EirGenix are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, EirGenix may actually be approaching a critical reversion point that can send shares even higher in December 2024.
SynCore Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

EirGenix and SynCore Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EirGenix and SynCore Biotechnology

The main advantage of trading using opposite EirGenix and SynCore Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EirGenix position performs unexpectedly, SynCore Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SynCore Biotechnology will offset losses from the drop in SynCore Biotechnology's long position.
The idea behind EirGenix and SynCore Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets